cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
-
Editorial Address
-
Location
Kab. sleman,
Daerah istimewa yogyakarta
INDONESIA
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)
Published by Universitas Gadjah Mada
ISSN : 20888139     EISSN : 24432946     DOI : -
Core Subject : Health,
Health Professions Medicine & Pharmacology Public Health
JMPF is the first open access journal in Indonesia specialized in both research of pharmaceutical management and pharmacy practice. Articles submitted in JMPF are peer reviewed, we accept review articles and original research articles with no submission/publication fees. JMPF receives manuscripts in both English (preferably) and Indonesian Language (Bahasa Indonesia) with abstracts in bilingual, both Indonesian and English. JMPF is also open for various fields such as pharmaceutical management, pharmacoeconomics, pharmacoepidemiology, clinical pharmacy, community pharmacy, social pharmacy, pharmaceutical marketing, goverment policies related to pharmacy, and pharmaceutical care.
Arjuna Subject : -
Articles 6 Documents
 1 
Search results for , issue "Vol 12, No 4" : 6 Documents clear
Importance Performance Analysis Pelayanan Farmasi Klinik di RS Universitas Sumatera Utara dalam Persepsi Perawat Rima Elfitra Rambe; Khairunnisa Khairunnisa; Wiryanto Wiryanto
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 12, No 4
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.73842

Abstract

Clinical Pharmacy Services (CPS) is provided by clinical pharmacists as members of the healthcare team. This is beneficial for hospital care. Therefore, knowing nurses' perception of CPS can determine the quality of healthcare provided and help in its improvement. This study aims to determine nurses' perception of clinical pharmacy services at the Universitas Sumatera Utara hospital, Medan, Indonesia. This is a descriptive study that used the Importance–Performance Analysis (IPA) method. The data were obtained by interviews and questionnaires to 60 nurses from October-December 2021. Five clinical pharmacy services are patient drug history, reconciliation, drug information services, recommendations and intervention in the integrated medical record, and sterile product dispensing. This study found that nurses have experienced the five clinical pharmacy services for as many as 52-60 people (87%-100%). Reconciliation, recommendations, and intervention in the integrated medical record are in Quadrant I.        It shows that the performance of these services has not met the nurses' expectations. Drug information services are in Quadrant II. It shows that the service performance has been in line with the expectations. The patient's drug history is in Quadrant III. It shows low performance and is not expected by the nurse. The sterile product dispensing by clinical pharmacists is in quadrant IV. It shows that even though the perceived performance is good, the respondents do not consider this service to be important.
Perancangan Clinical Decision Support System (CDSS) untuk Drug Drug Interaction (DDI) pada e-Prescription Resia Perwirani; Ika Puspitasari
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 12, No 4
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.74506

Abstract

Not all drugs side-effect that occur can be avoided, but those caused by drug-drug interactions (DDI) are among the most likely to be prevented and managed due to their predictability. The increasing number of drugs co-prescribed, affects the potential for drug interactions exponentially. Clinical Decision Support System (CDSS) is a promising strategy to prevent patient safety risks caused by drug interactions. This study aims to design a CDSS for DDI on e-Prescription. This research is qualitative study with action research design. The research was carried out at Digital Health Innovation Studio (DHIS) UGM, and at Budi Rahayu Hospital Magelang with the implementation time November 2021 - April 2022. Data collection for user needs analysis was carried out by interviewing management, doctors and pharmacists at the hospital, and also pharmacologists. Design and development of CDSS-DDI was executed in collaboration with DHIS UGM programmers. The evaluation was done by interviews and a System Usability Scale (SUS) questionnaire filled in by 17 system-related users. CDSS-DDI successfully developed according to user needs, it can be accessed by doctors and pharmacy units. The drug interaction warning display pop-up appears on one screen in the e-Prescription menu with a description of drug interactions in Bahasa. Drug interaction data refers to the National Drug Information Center (PIONas) which is managed by the POM. CDSS-DDI then implemented in hospital after going through socialization. Based on evaluation with SUS data processing tools, the CDSS-DDI received a score of 83 in the acceptable category and excellent rating. Based on results of evaluation interviews, CDSS for DDI is considered to have been successfully developed with the principle of user centered design and optimally efficient to help improve the quality of patient care.
Evaluasi Sistem Informasi Manajemen pada Laporan Pemakaian dan Lembar Permintaan Obat di Puskesmas X Mera Putri Pratitis; Jason Merari Peranginangin; Ika Purwidyaningrum
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 12, No 4
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.76079

Abstract

The required elements in drug procurement are usage and drug requisition report or Laporan Pemakaian dan Lembar Permintaan Obat (LPLPO). The application of the Management Information System (MIS) at X Public Health Center cannot fulfill the function of preparing the LPLPO, so it has an impact on the planning and procurement of the drug. This study aims to evaluate and determine the design of MIS development of LPLPO at X Public Health Center, Surakarta City. The study is a qualitative descriptive study with inductive analysis. The sampling in this study is a purposive sampling. The sample in this study were officers who operated SIM both pharmacists and assistant pharmacists for at least 1 year. This research was conducted at X Public Health Center Surakarta City in September-October 2021. The design of the system in this study uses the prototype method based on the results of interviews. Interviews were conducted as an evaluation of MIS using the PIECES Framework method involving 4 informants. The license design is made using the context diagram and the flow diagram data (DFD). The results of the evaluation with the PIECES Framework show that the MIS that is applied can provide convenience for users in managing drug supplies even though it has not been optimized and has not met the needs so that the MIS is feasible to be developed. Based on the results of the evaluation, it can be concluded that the application of MIS can help and facilitate pharmacists in carrying out their work by providing accurate and complete data and information as supporting data for the preparation of LPLPO, but it cannot be used to monitor expired date of drug and prepare automatic LPLPO.
Perbandingan Angka Kematian Terapi Antiviral Favipiravir dan Remdesivir pada Pasien COVID-19 Di RSUP Dr. Sardjito Yogyakarta Nova Satriyani; Fita Rahmawati; Tri Murti Andayani
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 12, No 4
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.77288

Abstract

Antiviral treatment for SARS-CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2) is still being studied for its effectivity. The antivirals in the July 3, 2021 edition of the COVID-19 management guidelines, namely favipiravir and remdesivir, are used for moderate, severe and critical degrees. The study compares the mortality rate of COVID-19 patients taking the antivirals favipiravir and remdesivir. This research is a retrospective cohort study conducted at RSUP Dr. Sardjito Yogyakarta. The data was from the medical records of patients diagnosed with moderate, severe, and critical degrees of COVID-19 treated during the January-December 2021 period. Ninety-nine patients (50.8%) used favipiravir, while 97 patients (49.5%) used remdesivir. Chi-square analysis and multiple logistic regression were used to determine the relationship between research variables. Study subjects with the highest percentage of age 46-65 years (65%), male sex (54,6%), comorbid diabetes mellitus and hypertension (13,3%), severe degree of severity (60,7%), and viral load CT value ≤ 29 (80,1%), the patient went home alive (61,2%), and died (38,8%). The antivirals did not affect on mortality (p > 0,05). Further research is needed with the same characteristics of the two groups involving factors of degree severity of the disease, co-morbidity, and other medication therapy.
Knowledge of Cardiovascular Disease and its Association Among General Population in Indonesia Bella Anggelina; Susi Ari Kristina; Chairun Wiedyaningsih
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 12, No 4
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.78070

Abstract

Knowledge of cardiovascular disease is essential for providing information about healthy behavior and to be proactive in reducing modifiable risk factors, control prevention, and improving early recognition. The existing study about knowledge of CVD in Indonesia is still limited. Hence, this study aimed to describe knowledge of CVD among general population in Indonesia and its association. A cross-sectional survey was conducted in 34 provinces in Indonesia from November-December 2021. Data were retrieved using a self-administered questionnaire. The Chi-Square analysis was performed to determine the association that contributes to overall knowledge of CVD. Among the 694 participants, 32.1% originated from Java, with the median age was 24 years and dominated by women (72.5%). The mean score of overall CVD knowledge was 59.6%, and only 39.1% of the participants had good knowledge of CVD. Cerebrovascular disease (94.7%) was the most identified various type of CVD. Likewise, unhealthy diet (77.2%), obesity (74.6%), and lack of exercise (72.5%) were the most identified risk factors. More than 50% of the participants recognized heart attack symptoms such as chest pain (77.1%) and shortness of breath (66.1%). Meanwhile, numbness or weakness (84.7%), trouble speaking (76.9%), and loss of balance (72.3%) were recognized as stroke symptoms. Gender, age, education level, working status, healthy food, smoking status, family history of CVD, ever checked blood pressure, fasting blood glucose, and total cholesterol were associated with overall knowledge of CVD. The disparity between level of CVD knowledge is not prominent among general population in Indonesia and further study need to establish.
Clinical and therapeutic characteristics of hospitalized cancer patients in the Najran Region of Saudi Arabia: a cross-sectional study Hamad S Alyami; Abdallah Y Naser; Mohammad H. Alyami; Ibraheem S. Banihameem; Mohammad Almusabi; Ahlam M. Alqahtani; Mohammed A. Gannas; Hadi S. Alyami; Hadi J. Al Sulayyim; Saeed F. Alkorbi; Hussain M. Alsagoor; Abdullah M. Alyami; Rubiaan S. Almadi; Salem Hussain Alharethi
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 12, No 4
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.78654

Abstract

There are limited studies in the Southern region of Saudi Arabia on the characteristics of hospitalised patients with cancer. The aim of this study was to explore the clinical and therapeutic characteristics of hospitalized cancer patients in the Najran Region of Saudi Arabia. A retrospective cross-sectional observational study was conducted using cancer patients’ medical records at the oncology unit in the King Khalid Hospital in Najran situated in the southern region of Saudi Arabia. Hospitalized patients’ records were extracted between 2014 and 2020. Logistic regression analysis was conducted to identify determinants of ICU admission among cancer patients. A total of 1,678 patients were involved in this study. The mean age was 52.5 (SD: 21.1) years. The average duration of stay was 8.7 days (SD: 13.4). The most commonly reported types of cancer were breast cancer, rectum cancer and colon cancer, accounting for 13.6%, 6.9%, and 6.7%, respectively. A total of 13.9% of the study participants required ICU admission. More than half (57.1%) of the patients were complaining of a moderate to severe case upon hospitalization. Older age (52.5 years and above) and the presence of comorbidities were risk factors that significantly increased the risk of ICU admission (P<.001). Patients with diabetes mellitus, hypertension, heart diseases, stroke, and kidney diseases were more likely to require ICU admissions. Patients with liver cancer were more likely to require ICU admission. Healthcare professionals should give extra care and health education for high risk cancer patients including elderly patients and those with other comorbidities to prevent complications and its associated hospitalization.

Page 1 of 1 | Total Record : 6

 1 

Filter by Year

2023 2023


Reset
Filter By Issues
All Issue Vol 15, No 3 Vol 15, No 2 Vol 15, No 1 Vol 14, No 4 Vol 14, No 3 Vol 14, No 2 Vol 14, No 1 Vol 13, No 4 Vol 13, No 3 Vol 13, No 2 Vol 13, No 1 Vol 12, No 4 Vol 12, No 3 Vol 12, No 2 Vol 12, No 1 Vol 11, No 4 Vol 11, No 2 Vol 1, No 3 Vol 11, No 3 Vol 11, No 1 Vol 10, No 4 Vol 10, No 3 Vol 10, No 2 Vol 10, No 1 Vol 9, No 4 Vol 9, No 3 Vol 9, No 2 Vol 9, No 1 Vol 8, No 4 Vol 8, No 3 Vol 8, No 2 Vol 8, No 1 Vol 7, No 4 Vol 7, No 3 Vol 7, No 2 Vol 7, No 1 Vol 6, No 4 Vol 6, No 3 Vol 6, No 2 Vol 6, No 1 Vol 5, No 4 Vol 5, No 4 Vol 5, No 3 Vol 5, No 3 Vol 5, No 2 Vol 5, No 1 Vol 4, No 4 Vol 4, No 3 Vol 4, No 2 Vol 4, No 1 Vol 3, No 4 Vol 3, No 3 Vol 3, No 2 Vol 3, No 1 Vol 2, No 4 Vol 2, No 3 Vol 2, No 2 Vol 2, No 1 Vol 1, No 4 Vol 1, No 2 Vol 1, No 1 More Issue